FY2025 EPS Estimates for Elevance Health Boosted by Analyst

Key Points

• Analysts at Cantor Fitzgerald have raised their FY2025 earnings per share (EPS) estimates for Elevance Health to $30.15, up from $30.00, indicating positive financial outlook for the company.
• Elevance Health reported quarterly earnings of $6.03 EPS, significantly surpassing analysts' consensus estimate of $5.03, along with a revenue of $50.09 billion, reflecting a 12% year-over-year increase.
• The company announced a quarterly dividend of $1.71 per share, which translates to an annualized dividend yield of 2.0%, showcasing continued shareholder return strategies.

Elevance Health, Inc. (NYSE:ELV - Free Report) - Analysts at Cantor Fitzgerald increased their FY2025 EPS estimates for Elevance Health in a research report issued to clients and investors on Wednesday, October 22nd. Cantor Fitzgerald analyst S. James now forecasts that the company will post earnings per share of $30.15 for the year, up from their prior estimate of $30.00. The consensus estimate for Elevance Health's current full-year earnings is $33.96 per share.

Elevance Health (NYSE:ELV - Get Free Report) last announced its quarterly earnings data on Tuesday, October 21st. The company reported $6.03 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.03 by $1.00. Elevance Health had a net margin of 2.84% and a return on equity of 16.31%. The firm had revenue of $50.09 billion for the quarter, compared to analysts' expectations of $49.26 billion. During the same period last year, the firm earned $8.37 earnings per share. The business's revenue for the quarter was up 12.0% on a year-over-year basis.

Several other equities research analysts have also weighed in on ELV. The Goldman Sachs Group started coverage on shares of Elevance Health in a report on Tuesday, October 14th. They issued a "neutral" rating and a $343.00 target price on the stock. Wall Street Zen lowered shares of Elevance Health from a "buy" rating to a "hold" rating in a report on Friday, July 18th. Weiss Ratings upgraded shares of Elevance Health from a "sell (d+)" rating to a "hold (c-)" rating in a report on Wednesday, October 8th. Wells Fargo & Company cut their target price on shares of Elevance Health from $412.00 to $403.00 and set an "overweight" rating on the stock in a report on Wednesday. Finally, Argus reiterated a "hold" rating on shares of Elevance Health in a report on Monday, July 21st. Ten equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat, Elevance Health has an average rating of "Moderate Buy" and an average target price of $398.94.

Elevance Health Price Performance

Shares of ELV stock opened at $344.88 on Thursday. Elevance Health has a 52-week low of $273.71 and a 52-week high of $458.75. The stock has a market cap of $77.66 billion, a PE ratio of 14.10, a PEG ratio of 1.28 and a beta of 0.59. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.44 and a current ratio of 1.44. The firm's 50 day moving average price is $325.40 and its two-hundred day moving average price is $354.52.

Elevance Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 19th. Investors of record on Friday, December 5th will be issued a dividend of $1.71 per share. This represents a $6.84 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date is Friday, December 5th. Elevance Health's dividend payout ratio (DPR) is presently 29.11%.

Insider Activity at Elevance Health

In related news, Director Susan D. Devore acquired 1,200 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The shares were acquired at an average cost of $312.15 per share, for a total transaction of $374,580.00. Following the completion of the acquisition, the director directly owned 3,502 shares in the company, valued at approximately $1,093,149.30. The trade was a 52.13% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.29% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Elevance Health

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. raised its holdings in shares of Elevance Health by 3.2% during the second quarter. Vanguard Group Inc. now owns 22,856,898 shares of the company's stock worth $8,890,419,000 after acquiring an additional 704,790 shares during the period. Sanders Capital LLC raised its holdings in shares of Elevance Health by 24.7% during the second quarter. Sanders Capital LLC now owns 5,825,208 shares of the company's stock worth $2,265,773,000 after acquiring an additional 1,152,440 shares during the period. Artisan Partners Limited Partnership increased its stake in Elevance Health by 9.7% in the 2nd quarter. Artisan Partners Limited Partnership now owns 3,675,179 shares of the company's stock valued at $1,429,498,000 after buying an additional 324,399 shares during the last quarter. Norges Bank acquired a new stake in Elevance Health in the 2nd quarter valued at $1,148,379,000. Finally, Orbis Allan Gray Ltd increased its stake in Elevance Health by 31.4% in the 1st quarter. Orbis Allan Gray Ltd now owns 2,849,173 shares of the company's stock valued at $1,239,276,000 after buying an additional 680,228 shares during the last quarter. 89.24% of the stock is currently owned by institutional investors and hedge funds.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.